Loading the session
Loading the session
Loading instrument
$182.58
+0.00%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:39 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
Closed at $182.58 on 4 Nov 2026: 0.7% below the 52-week high of $183.90 (2 Mar 2026) and 24.1% above the low of $147.18 (9 Dec 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026
The 4 Nov 2026 close of $182.58 was 7.4% above its 50-day average ($170.06) and 7.8% above its 200-day average ($169.44). It has closed above the 200-day for 5 sessions, since 29 Oct 2026. The 50-day average crossed above the 200-day on 4 Aug 2026, 65 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
The 4 Nov 2026 gain of 4.0% was 4.1× its average daily move of 1.0% over the past year, and its largest one-day gain since 11 Dec 2025.
Daily closes, split-adjusted · as of 4 Nov 2026
1 month: +10.5% (SPY −1.6%, XLB +8.4%). 3 months: +2.1% (SPY −0.4%, XLB +2.4%). 1 year: +20.2% (SPY +13.6%, XLB +27.2%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BCPC, SPY and XLB · as of 4 Nov 2026
4 Nov 2026 volume of 452.5K shares was 1.6× the average of the 30 sessions before it (275.2K), as the price rose 4.0%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
April 30, 2026
−6.76%December 5, 2022
−6.95%November 10, 2022
+6.28%